[Silicotuberculosis and ethambutol treatment].
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007273:Injections, Intramuscular; D007538:Isoniazid / Q000008:administration & dosage; D008875:Middle Aged; D012830:Silicotuberculosis / Q000097:blood / Q000188:drug therapy*; D013183:Sputum / Q000032:analysis; D013307:Streptomycin / Q000008:administration & dosage; D000637:Transaminases / Q000097:blood; D014786:Vision Disorders / Q000139:chemically induced
D000995:Antitubercular Agents; D001798:Blood Proteins; D004977:Ethambutol; D000637:Transaminases; D000469:Alkaline Phosphatase; D007538:Isoniazid; D013307:Streptomycin
Siliko-Tuberkulose und Ethambutol-Behandlung.